Purpose: We aim to describe ophthalmic characteristics and systemic findings in a cohort of seven patients with cone-rod retinal dystrophy (CORD) caused by pathogenic variants in the ALMS1 gene. Methods: Seven patients with Alstr€ om syndrome (ALMS) were included in the study. A comprehensive ophthalmological examination was performed, including best-corrected visual acuity (BCVA), a semiautomated kinetic visual field exam, colour vision testing, full-field electroretinography testing according to International Society for Clinical Electrophysiology of Vision (ISCEV) standards, spectral domain optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF) imaging, and slit lamp and dilated fundus examination. DNA samples were analysed using Sanger sequencing or exome sequencing. Results: In our cohort, the ocular phenotype presented with a wide variability in retinal function and disease severity. However, age of symptom onset (i.e. nystagmus and photophobia) was at 6-9 months in all patients. These symptoms mostly mislead to the diagnosis of congenital achromatopsia (ACHM), Leber congenital amaurosis (LCA), isolated CORD or Bardet-Biedl syndrome. The systemic manifestations in our cohort were highly variable. Conclusion: In summary, we can report that most of our ALMS patients primarily presented with nystagmus and severe photophobia since early childhood interestingly without night blindness in the absence of systemic symptoms. Only genetic testing analysing both nonsyndromic retinal disease (RD) genes and syndromic ciliopathy genes by comprehensive panel sequencing can result in the correct diagnosis, genetically and clinically, with important implication for the physical health of the individual.
Introduction
Alstr€ om syndrome (ALMS, OMIM# 203800) is classically described as a rare, multisystemic hereditary disorder that is characterized by a progressive loss of vision due to CORD leading to juvenile blindness, sensorineural hearing loss, obesity, insulin resistance with hyperinsulinemia and type 2 diabetes mellitus (Marshall et al. 2007a ) ALMS patients exhibit signs and symptoms similar to those of Bardet-Biedl and Laurence-Moon syndrome, all of which are considered ciliopathies (Aliferis et al. 2012; Alstrom et al. 1959 , Russell-Eggitt et al. 1998 . Additional disease phenotypes that may severely affect prognosis and survival include dilated cardiomyopathy, pulmonary fibrosis and restrictive lung disease, and progressive hepatic and renal failure (Marshall et al. 2007a ). Other clinical features in some patients include hypertension, hypothyroidism, hyperlipidemia, hypogonadism, urological abnormalities, adult short stature, bone-skeletal disturbances and acanthosis nigricans (Marshall et al. 1993 ). Most patients demonstrate normal intelligence, though some reports indicate delayed psychomotor and intellectual development (Marshall et al. 2007a) . The lifespan of patients with ALMS rarely exceeds 40 years (Marshall et al. 2007a) . The prevalence estimate is less than one in a million people globally (Van Groenendael et al. 2015) . There is no specific therapy for ALMS, but early diagnosis and intervention can moderate the progression of some of the disease phenotypes and improve the longevity and quality of life for the patients (Van Groenendael et al. 2015) .
Alstr€om syndrome (ALMS) is inherited in an autosomal recessive e445 manner and caused by pathogenic variants in the gene 'Alstr€ om syndrome 1 0 (ALMS1, OMIM# 606844) located on chromosome 2p13.1 (Collin et al. 1997 (Collin et al. , 2002 Hearn et al. 2002) . The molecular function of ALMS1 is currently not completely understood, but it is suggested to play a role in cell cycle regulation and intraciliary transport, extracellular matrix production and cell migration, and endosomal trafficking (Hearn et al. 2005; Knorz et al. 2010; Zulato et al. 2011; Collin et al. 2012; Leitch et al. 2014; Shenje et al. 2014) . It is expressed highest in testis, moderate in brain, eye, lung and olfactory bulb, and low in spleen, liver and kidney (Li et al. 2007 ). Alms1 À/À knockout mice develop features similar to human patients with ALMS, including obesity, hypogonadism, hyperinsulinemia, retinal dysfunction and late-onset hearing loss . Alms1 À/À mice display abnormal auditory brainstem responses after 8 months of age. Retinal malfunction is characterized by early diminished cone electroretinogram (ERG) b-wave response, followed by the degeneration of photoreceptor cells. Electron microscopy studies have revealed accumulation of intracellular vesicles in the inner segments of photoreceptors, whereas immunohistochemical analysis has shown mislocalization of rhodopsin to the outer nuclear layer. Therefore, ALMS1 was suggested to play a role in intracellular trafficking . Of the 281 pathogenic variants in ALMS1 that have been identified so far (HGMD professional 2016. 3), the majority are not found in homozygosity, demonstrating the fact that the patients were not born to related parents, and most pathogenic variants likely lead to the complete loss of the ALMS1 polypeptide (Marshall et al. 2015) .
The main ophthalmological characteristics of the disease are not present at birth, but develop within a few weeks to months of age presenting with a horizontal nystagmus with limited amplitude, a more or less marked light sensitivity (photophobia), and poor vision (Marshall et al. 2007a; Van Groenendael et al. 2015) . Initially, the fundus appearance may be normal or near normal, eventually progressing to retinal dystrophy exhibiting attenuated vessels, pale optic discs and partial atrophy of the retinal pigment epithelium (RPE) without intraretinal pigment migration (Marshall et al. 2007a; Khan et al. 2015) . In the beginning of the disease, the photopic ERG is affected suggesting a cone dystrophy, eventually rapidly progressing to the findings of a typical CORD (Tremblay et al. 1993) . The peripheral visual field is usually affected in the first decade of life, and loss of vision occurs in the second decade of life (Malm et al. 2008) .
The aim of this study is to describe ophthalmic characteristics and systemic findings in a cohort of seven patients with CORD caused by pathogenic variants in the ALMS1 gene, focusing on the retinal phenotype, the organ that -in the majority of the patients -manifests disease first.
Materials and Methods
The study was conducted in accordance with the Declaration of Helsinki with approval from the ethics committee of the University of Tuebingen. Written informed consent was obtained from all adult patients and parents/ guardians of minors.
Seven ALMS patients were included in the study: a 9 yo male, a 15 yo male, a 17 yo female, a 21 yo female, a 24 yo male, and two 21-and 26 yo females (sisters). A comprehensive ophthalmological examination was performed, either in a clinical routine setting or in a research setting.
Psychophysical tests
Best-corrected visual acuity (BCVA) was assessed with a retroillumated Early Treatment Diabetic Retinopathy Study (ETDRS) chart (Told et al. 2013) . Semiautomated kinetic visual field tests were performed with an Octopus 900 perimeter (Haag-Streit International, Wedel, Germany) using Goldmann stimuli III4e and V4e within the 90°visual field (Schiefer et al. 2005a,b) . Colour vision tests were performed with Farnsworth Panel D-15 colour vision cups (Melamud et al. 2004) . Slit lamp and dilated fundus examination were performed after applying eye drops containing tropicamide and neosynephrine.
Electrophysiology
Full-field ERG testing was performed according to the standards of the ISCEV under scotopic and photopic lighting conditions using the Espion device (Diagnosys, Lowell, Massachusetts, USA) (Marmor et al. 2009; McCulloch et al. 2015) .
Retinal imaging
Spectral domain optical coherence tomography (SD-OCT) and FAF images were acquired using the Spectralis HRA+ OCT unit (Heidelberg Engineering, Heidelberg, Germany). For optical coherence tomography (OCT) imaging, line scans and, where possible, volume scans were acquired.
As can be seen in the Results section, most of the patients had severe visual impairment in addition to photophobia and nystagmus resulting in difficulties in performing tests and the acquisition of images. Thus, the authors decided not to apply a more specific/rigid testing protocol.
Patient blood samples were collected after informed consent, and DNA was extracted according to standard procedures. DNA samples were analysed using Sanger sequencing, a capture panel of syndromic and nonsyndromic RD genes (CeGaT GmbH, Tuebingen, Germany) or exome sequencing either in a research or in a diagnostic genetic setup. Details of panel design, library preparation, capture sequencing and variant calling have already been published as have been for the exome sequencing (Gl€ ockle et al. 2014; Weisschuh et al. 2016 ). All putative pathogenic variants identified by panel or exome sequencing were validated and tested for co-segregation (5 of 7 cases) using conventional Sanger sequencing according to the manufacturer's protocols (3130XL Sequencer, Applied Biosystems, Weiterstadt, Germany).
Results
Our cohort of seven ALMS patients consisted of a 9 yo male (BD220), a 15 yo male (BD170), a 17 yo female (BD223), a 21 yo female (BD210), a 24 yo male (BD191), and two 21-and 26 yo females (sisters: BD221-II:2 and BD221-II:1). The pathogenic variants were seen in homozygous state in two patients and in apparent homozygous state in two patients, respectively. Compound heterozygosity was observed for two pathogenic variants in two patients. In one patient with characteristic Alstr€ om phenotype, only one pathogenic variant was observed ( Table 1) . The patient was included in this study. The pathogenic variants were either nonsense or small insertion or deletion mutations resulting in frame-shift and premature termination codon. All pathogenic variants are predicted to undergo nonsense-mediated mRNA decay and therefore most likely represent null alleles (Frischmeyer & Dietz 1999) . Three pathogenic variants were novel: two nonsense mutations (c.1046G>A;p.W349* and c.7141C>T;p.Q2381*) and a 2 bp deletion (c.2317_2318delAT; p.I773Ffs*13) ( Table 1 ).
All patients presented with nystagmus from early childhood on (6-9 months). Photophobia was present from early childhood on as well, except for one patient (15 yo male BD170) who developed photophobia at the age of 2 years. Colour vision defects were reported in five patients: in two of them (21-and 26 yo sisters BD221-II:2 and BD221-II:1) from early childhood (4 years old) on and in one patient (15 yo male BD170) at the age of 2 years. The other two patients (17 yo female BD223 and 24 yo male BD191) could not be tested. Interestingly, none of the patients reported night blindness (Table 1) .
All patients exhibited symmetric hyperopia (ranging from +4.00 to +11.25 dioptres) and with-the-rule astigmatism (ranging from À1.00 to À4.00 dioptres). The visual acuity (VA) was reduced to the perception of light in two patients (21 yo female BD210 and 24 yo male BD191), hand motion in two patients (15 yo male BD170 and 21 yo female BD221-II:2) and 20 of 640 to 20 of 800 in three patients (9 yo male BD220, 17 yo female BD223 and 26 yo female BD221-II:1). The visual field was not recordable in all but two patients, one of whom (26 yo female BD221-II:1) had a visual field constriction to 20°-45°i n the left eye using the III4e isopter and a crescent of visual field paracentral inferiorly in the right eye using the V4e isopter. The other patient (17 yo female BD223) had a visual field constriction to within 10°in both eyes using the V4e isopter (Table 1, Fig. 1 ).
Anterior segment evaluation showed a posterior subcapsular cataract in both eyes in three patients (17 yo female BD223, 21 yo and 26 yo sisters BD221-II:2 and BD221-II:1). Cataract surgery had been performed in both Mutation nomenclature refers to GenBank reference sequence NM_015120.4 for ALMS1. The one-letter amino acid code is given.
eyes in one patient (24 yo male BD191). One patient (21 yo female BD210) had exotropia of the left eye. Dilated fundus examination revealed mostly uniform alterations in all patients, which were pallor of the optic disc, macular pigmentary changes, narrow blood vessels, atrophic RPE in the mid-periphery but no bone spicules (Fig. 2) . General rarefication of the RPE was observed in one patient (9 yo male BD220). Focal areas of pigment clumping were observed in two patients (17 yo female BD223 and 26 yo female BD221-II:1). Focal areas of crystalline deposits similar in appearance but fewer than those found in Bietti crystalline dystrophy were observed in four patients (21 yo female BD210, 21 yo female BD221-II:2, 24 yo male BD191 and 26 yo female BD221-II:1; Fig. 2 ) (Yuzawa et al. 1986 ). Infrared reflectance imaging revealed few bright spots similar to crystalline deposits in the same patients and a speckled pattern in one patient (21 yo female BD210). Fundus autofluorescence (FAF) imaging revealed medium-sized round hypoautofluorescent spots outside the arcades in one patient (21 yo female BD221-II:2), inside and outside the arcades in one patient (24 yo male BD191), a parafoveal hyperautofluorescent ring in two patients (15 yo male BD170 and 24 yo male BD191) and a small area of hypoand in one eye hypo-and hyperautofluorescence in one case (26 yo female BD221-II:1; Fig. 3 ). Optical coherence tomography (OCT) images were available from six of the seven patients. Two of the patients (15 yo male BD170 and 24 yo male BD191) showed general atrophy of both the inner and outer retinal layers. The major finding in the other four patients was a thinning of the outer nuclear layer and the outer plexiform layer outside the fovea, as well as a mild epiretinal membrane (Fig. 4) . Electroretinography (ERG) testing revealed extinguished dark-adapted rod and light-adapted cone responses in all patients (Fig. 5) .
Differential diagnoses before ALMS was diagnosed were ACHM in four patients (9 yo male BD220, 15 yo male BD170, and the 21 yo and 26 yo sisters BD221-II:2 and BD221-II:1) at first, and later, LCA was considered in one patient (9 yo male BD220). In two patients (21 yo female BD210 and 24 yo male BD191), the differential diagnosis was Bardet-Biedl syndrome, and in one patient (17 yo female BD223), the differential diagnosis was CORD at first. In our cohort, ALMS was diagnosed between the ages of 9 and 24 years (Table 1) .
Systemic disease was present in five of the seven patients ( Table 2 ).
The 9 yo male patient (BD220) did not show any obvious systemic symptoms. His mental abilities were not impaired. At the age of 12 years, a thorough systemic instrumental and laboratory investigation was performed and evidenced: hearing difficulties, both hyperinsulinemia and impaired glucose tolerance, elevated liver transaminases, nephrocalcinosis I°and restrictive lung disease.
The 21 yo female patient (BD221-II:2) did not suffer from any other systemic symptoms with the exception of occipital headache since the age of 13. Her mental abilities were not impaired. She had regular menses and her weight had always been normal, also when she was a child. At the age of 21, a thorough systemic instrumental and laboratory investigation was performed and evidenced: normal heart and liver function, a normal lipid profile, normal levels of glycaemia and insulin after oral glucose tolerance test, and normal kidney function. She had low vitamin D levels. On physical examination, she had no gross alteration of the face or body shape. Fig. 1 . Semiautomated kinetic visual field testing using Goldmann stimuli III4e and V4e within the 90°visual field in patients with Alstr€ om syndrome showing varying degrees of visual field constriction. The red and blue outlines mark the borders of the visual field that would be expected in a healthy individual using the respective stimulus. In some patients, especially in those with a severe visual field constriction using the III4e stimzlus (red line), visual field testing was performed using the V4e stimulus (blue line). The 15 yo male patient (BD170) exhibited dilated cardiomyopathy at the age of 8 weeks followed by valve insufficiency and nephrocalcinosis type IIa. The patient also developed sensorineural hearing loss requiring hearing aids at the age of 7 years. Additionally, he exhibited obesity, pituitary hypogonadism with a normal function of the thyroid, liver steatosis and asthma. His mental abilities were reduced. There was a positive family history with several cases of blindness due to an unknown cause without any evidence for consanguinity.
The 17 yo female patient (BD223) suffered from myocarditis as a baby, hearing difficulties, obesity, hypothyroidism, type 2 diabetes mellitus and scoliosis. Her mental abilities were not impaired.
The 21 yo female patient (BD210) suffered from obesity, hypothyroidism, hypertension, type 2 diabetes mellitus, and pseudo acanthosis. Her mental abilities were reduced.
The 24 yo male patient (BD191) suffered from hearing difficulties, type 2 diabetes mellitus and renal insufficiency. His mental abilities were not impaired.
The 26 yo female patient (BD221-II:1) did not show symptoms of the systemic disease until the age of 17. She developed first signs of hearing difficulties approximately at the age of 17 and required hearing aids at the age of 19. Hypertension was diagnosed at the age of 24 and treated with chlorthalidone. At the same age, oral glucose tolerance testing was performed revealing both hyperinsulinemia and impaired glucose tolerance. The patient had a normal body weight, no history of hyperphagia or overweight also when she was a child, and always regular menses. Her mental abilities were not impaired. A thorough instrumental, laboratory and clinical investigation was performed at the age of 24 not showing any significant alterations of the heart or kidney function. However, liver transaminases were elevated and almost normalized after a low carbohydrate diet within 2 months. Low vitamin D levels were also evidenced. A thyroid nodule was found as incidental finding during a carotid artery ultrasound which was otherwise reportedly normal. On physical examination, she had no gross alteration of the face or body shape.
Discussion
In our cohort, the ocular phenotype presented with a wide variability in retinal function and disease severity. However, age of symptom onset at 6-9 months (i.e. nystagmus and photophobia) was similar to what has been described before (Marshall et al. 2007a) . These symptoms mostly mislead to the diagnosis of congenital ACHM, LCA, isolated CORD or Bardet-Biedl syndrome.
Four patients exhibited posterior subcapsular cataract or had performed cataract surgery from the age of 17 years in addition to the high symmetric hyperopia which all of the patients in our cohort exhibited (Khan et al. 2015) . The funduscopic alterations in our cohort were in line with previous findings, as were the ERG findings showing extinguished cone and rod responses in all patients from the age of 9 years (Tremblay et al. 1993; Marshall et al. 2007a) .
One patient in our cohort (26 yo female BD221-II:1) exhibited a particularly mild phenotype when compared to the other patients (and their respective age). A variability in retinal function and disease severity has been described before in a small cohort of three patients, in which one patient had a more benign clinical phenotype with no signs of nystagmus, an almost normal fundus appearance, stable VA of 20 of 100 up to the age of 10 years with preserved visual fields and only slightly reduced cone responses (Malm et al. 2008 ). However, this patient was notably younger than the 26 yo patient BD221-II:1 reported in this study.
In all the patients who underwent OCT imaging (6 of 7), we evidenced atrophy of the outer retina outside the fovea. Two of the six patients showed general atrophy of both the inner and outer retinal layers. Two cases of ALMS with OCT imaging have been reported previously: in these subjects, at age 8 and 13 years, respectively, the macula showed generalized retinal thinning, especially of the outer retinal layers, but less so at the fovea, where inner retinal layers were [abnormally] present (Khan et al. 2015) . Retinal immaturity has been reported by other authors, with only a single layer of short thick cones and rods as well as immature short outer segments (Vingolo et al. 2010) . Though the ocular features of ALMS have always been explained as a cone-rod dystrophy, the authors conclude that ALMS retinopathy is characterized by the arrest of macular development and abnormal persistence of the early retinal structural organization, and that this finding may explain why these patients experience an earlier and more severe visual loss than typical cone dystrophies (Vingolo et al. 2010) . In contrast to these findings, a line scan showing a foveal pit with regular thinning of the inner retinal layers could be acquired all six patients from our cohort who underwent OCT imaging.
The systemic manifestations in our cohort were highly variable. Interestingly, one patient did not show systemic symptoms, even at the age of 21 years BD221-II:2. Her 26 yo sister BD221-II:1 had not suffered from systemic symptoms until the age of 21, as well. The average age of onset for diabetes in ALMS is 16 years, and the age of onset of the restrictive cardiomyopathy ranges from 12 to 40 years. Renal disease typically does not emerge until late adolescence (Marshall et al. 2005 (Marshall et al. , 2015 . Thus, it is possible that the aforementioned patient will eventually show systemic symptoms later in life. 
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On the other hand, thorough follow-up examinations of patients with presumed nonsyndromic ALMS1-associated CORD have revealed mild or even absent systemic manifestations of ALMS (Xu et al. 2015) . In our cohort, the degree of systemic manifestations corresponded to the retinal function.
All pathogenic ALMS1 variants identified in our cohort most likely result in the complete loss of ALMS polypeptide and/or function. The spectrum of pathogenic variants comprised three nonsense and six small insertion or deletion mutations, all resulting in frame-shift and premature termination codon, and all are predicted to undergo nonsense-mediated decay, which is in line with the spectrum of pathogenic variants published to date. One patient (17 yo female BD223) was included in the study despite the fact that only one pathogenic variant could be determined, as she exhibited the characteristic Alstr€ om phenotype. The 'missing' mutated ALMS1 allele in this patient may harbour other types of molecular lesions including large deletions, chromosomal translocations, promoter/enhancer defects, or splice site alterations, intronic nucleotide variants more than 20 nucleotides from the intron-exon boundary, or variants in a nonexonic regulatory motif, which we have not analysed in our screening. Whole genome sequencing with structural variant detection may identify these missing alleles. Alternatively, it cannot be excluded that this patient may have mutations in another disease gene which might be identified through exome or genome sequencing.
Today, we do not yet have evidence for prognostic predictions based on the genotype (Marshall et al. 2015) .
Our study is not without limitations. In our cohort, the completeness of the records was variable from patient to patient, mainly hampered by the fact that the systemic workup was performed outside our facility. Annual review clinics in a multidisciplinary team have been suggested for tertiary referral centres like ours with exams individually tailored to the complex needs of patients with ALMS and other ultra-rare diseases for the convenience of the patients but also to serve as nuclei in driving large-scale research in ultra-rare diseases such as ALMS (Van Groenendael et al. 2015) .
In summary, we can report that our patients present with CORD, interestingly without night blindness, but with nystagmus and severe photophobia from early childhood on. The primary clinical diagnosis in our cohort was mostly congenital ACHM because of nystagmus and photophobia. Thus, the important point to make is that early in childhood, the ocular phenotype of ALMS may resemble that of a patient with isolated ACHM or LCA or CORD, especially in the absence of systemic symptoms that may not yet be manifested. This diagnosis can be misleading, and only comprehensive genetic testing analysing both nonsyndromic RD genes and syndromic ciliopathy genes by comprehensive panel sequencing can result in the correct diagnosis, genetically and clinically, with important implication for the physical health of the individual.
